Related Experiment Video

Updated: Jul 8, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

Hans-Guido Wendel1, Elisa De Stanchina, Jordan S Fridman

  • 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.

Nature
|March 19, 2004
PubMed

Insights

Cancer cells evade apoptosis, a key process in tumor development and drug resistance. Targeting Akt signaling with rapamycin can reverse chemotherapy resistance in certain lymphomas, offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Evading apoptosis is a hallmark of cancer, contributing to tumorigenesis and drug resistance.
  • Akt, an apoptotic regulator, is activated in many cancers and linked to drug resistance, but its precise role is unclear.

Purpose of the Study:

  • To investigate the role of Akt in apoptosis evasion, tumorigenesis, and drug resistance in a murine lymphoma model.
  • To determine if targeting Akt signaling can restore chemosensitivity in drug-resistant lymphomas.

Main Methods:

  • Utilized a murine lymphoma model to study Akt signaling.
  • Administered the mTOR inhibitor rapamycin to assess its effect on chemoresistance.
  • Investigated the role of eIF4E as a downstream effector of Akt.

Main Results:

  • Akt activation promotes tumorigenesis and drug resistance by disrupting apoptosis.
  • Rapamycin reversed chemoresistance in lymphomas with Akt defects but not those with other apoptotic mutations.
  • eIF4E recapitulated Akt's effects but did not confer sensitivity to rapamycin or chemotherapy.

Conclusions:

  • Akt signaling through mTOR and eIF4E is a critical mechanism for oncogenesis and drug resistance in vivo.
  • Targeting apoptotic pathways can restore drug sensitivity in a genotype-dependent manner, highlighting personalized treatment approaches.

More Related Videos

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.